Cambiar Investors LLC Biogen Inc. Transaction History

Cambiar Investors LLC

$2.47 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$223.92 - $287.77 $41.5 Million - $53.3 Million	-185,118 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$282.99 - $369.05 $876,420 - $1.14 Million	3,097 Added 1.7%	185,118 $52.4 Million
Q2 2021 Aug 02, 2021	BUY	$259.0 - $414.71 $5.78 Million - $9.25 Million	22,300 Added 13.96%	182,021 $63 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $515,782 - $604,269	2,123 Added 1.35%	159,721 $44.7 Million
Q4 2020 Feb 03, 2021	BUY	$236.26 - $355.63 $15.6 Million - $23.5 Million	65,998 Added 72.05%	157,598 $38.6 Million
Q3 2020 Oct 21, 2020	SELL	$264.77 - $305.71 $899,688 - $1.04 Million	-3,398 Reduced 3.58%	91,600 $26 Million
Q2 2020 Aug 03, 2020	BUY	$258.66 - $342.55 $522,234 - $691,608	2,019 Added 2.17%	94,998 $25.4 Million
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $1.79 Million - $2.27 Million	-6,643 Reduced 6.67%	92,979 $29.4 Million
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $6.3 Million - $8.71 Million	-28,644 Reduced 22.33%	99,622 $29.6 Million
Q3 2019 Oct 17, 2019	BUY	$217.44 - $243.88 $1.26 Million - $1.41 Million	5,778 Added 4.72%	128,266 $29.9 Million
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $5.72 Million - $6.3 Million	-26,072 Reduced 17.55%	122,488 $28.6 Million
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $10.5 Million - $16.4 Million	48,372 Added 48.28%	148,560 $35.1 Million
Q4 2018 Jan 24, 2019	SELL	$278.5 - $352.75 $4.29 Million - $5.43 Million	-15,404 Reduced 13.33%	100,188 $30.1 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $23.3 Million - $30.4 Million	-79,300 Reduced 40.69%	115,592 $40.8 Million
Q2 2018 Jul 18, 2018	SELL	$257.52 - $306.91 $1.27 Million - $1.51 Million	-4,935 Reduced 2.47%	194,892 $56.6 Million
Q1 2018 Apr 26, 2018	BUY	$260.13 - $367.91 $2.77 Million - $3.92 Million	10,658 Added 5.63%	199,827 $54.7 Million
Q4 2017 Jan 30, 2018	SELL	$307.64 - $344.58 $4.72 Million - $5.29 Million	-15,340 Reduced 7.5%	189,169 $60.3 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $57.5 Million - $67.4 Million	204,509	204,509 $64 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Account